欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (12): 1378-1390.doi: 10.12092/j.issn.1009-2501.2023.12.008

• 综述与讲座 • 上一篇    下一篇

以哺乳动物雷帕霉素靶蛋白为靶点治疗阿尔茨海默病的研究进展

王  准1,2,孙谕莹1,2,黄汉昌1,2   

  1. 1北京联合大学功能因子与脑科学研究院,北京  100023;2北京联合大学天然产物开发与创新药物研究重点实验室,北京  100023

  • 收稿日期:2023-04-26 修回日期:2023-07-27 出版日期:2023-12-26 发布日期:2023-12-21
  • 通讯作者: 黄汉昌,男,博士,教授,研究方向:阿尔茨海默病发病机理及干预作用研究。 E-mail: hanchang@buu.edu.cn
  • 作者简介:王准,男,汉族,硕士研究生,研究方向:阿尔茨海默病发病机制及生物活性物质对其干预作用。 E-mail: 2740235703@qq.com
  • 基金资助:
    国家自然科学基金(31471587);北京联合大学科研项目(ZKZD202304,ZK70202101)

Research progress on the treatment of Alzheimer's disease based on the target of mammalian target of rapamycin

WANG Zhun1,2, SUN Yuying1,2, HUANG Hanchang1,2   

  1. 1Institute of Functional Factors and Brain Sciences, Beijing Union University, Beijing 100023, China; 2Key Laboratory of Natural Products Development and Innovative Drug Research, Beijing Union University, Beijing 100023, China
  • Received:2023-04-26 Revised:2023-07-27 Online:2023-12-26 Published:2023-12-21

摘要:

哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)调节细胞存活、增殖和代谢。阿尔茨海默病(Alzheimer's disease,AD)是一种常见的神经系统退行性疾病,发病机理复杂,与衰老密切相关。研究发现,AD的病理发展过程中经常伴随着mTOR活性的变化,但尚不清楚mTOR在AD发病机制中的作用。本文首先介绍了mTOR的复合物及其信号通路,重点综述了mTOR信号通路对突触可塑性和记忆功能、自噬作用、β-淀粉样蛋白(amyloid-β,Aβ)、Tau蛋白和脑胰岛素抵抗等AD病理特征的影响,其次阐述了mTOR两种信号通路在抗衰老和延长寿命方面的调控作用,最后介绍了mTOR抑制剂在AD病理研究中的应用,为延缓和改善AD提供新的思路。

关键词: 哺乳动物雷帕霉素靶蛋白, 阿尔茨海默病, 自噬作用, 衰老, mTOR抑制剂

Abstract:

Mammalian target of rapamycin (mTOR) regulates cell survival, proliferation, and metabolism. Alzheimer's disease (AD) is a common neurodegenerative disease with a complex pathogenesis and is closely related to aging. Studies have found that the pathological development of AD is often accompanied by changes in mTOR activity, but the role of mTOR in the pathogenesis of AD is not clear. In this paper, the complex of mTOR and its signaling pathways are first introduced, focusing on the effects of mTOR signaling pathways on synaptic plasticity and memory function, autophagy, β-amyloid-β (Aβ), Tau protein and brain insulin resistance and other AD pathological features, secondly, the regulatory effects of mTOR signaling pathways in anti-aging and life prolongation are described, and finally the application of mTOR inhibitors in AD pathological research is introduced to provide new ideas for delaying and improving AD.

Key words: mammalian target of rapamycin, Alzheimer's disease, autophagy, aging, mTOR inhibitors

中图分类号: